Sleep Apnea Neurostimulation Devices Market
完整報告名稱與涵蓋範圍
Sleep Apnea Neurostimulation Devices Market Size, Share & Trends Analysis Report, By Device Type (Hypoglossal Nerve Stimulation Implants, Phrenic Nerve Stimulation for Central Sleep Apnea, Non-Implanted Daytime Neuromuscular Stimulation Devices, Emerging Bilateral and Leadless Stimulation Systems), By Indication (Moderate to Severe Obstructive Sleep Apnea with CPAP Intolerance, Central Sleep Apnea, Mild Obstructive Sleep Apnea and Snoring), By End User (Hospitals and Surgical Centers, Sleep Medicine and ENT Clinics, Home and Outpatient Use), By Region, and Segment Forecasts, 2026-2035
報告摘要
The sleep apnea neurostimulation devices market covers implantable hypoglossal nerve stimulators for obstructive sleep apnea, phrenic nerve stimulators for central sleep apnea, non-implanted daytime neuromuscular stimulation devices and emerging bilateral and leadless systems. Positive airway pressure equipment, oral appliances and diagnostic sleep testing are excluded but analysed as the treatment context and referral pathway; oral appliance makers are referenced as adjacent competitors.
Growth is driven by the large population of patients who cannot tolerate positive airway pressure therapy, by reimbursement coverage of hypoglossal stimulation in the United States and several European markets, by expanded eligibility to higher body mass index thresholds and by a growing base of trained implanting surgeons and sleep centers. Manufacturers are introducing smaller implants, sensor-free designs, bilateral stimulation, patient apps and remote monitoring, while daytime stimulation devices target mild disease and snoring through non-surgical routes. Competition from incretin-based weight loss drugs that reduce apnea severity, prior authorization requirements and surgical capacity are the main moderating factors.
North America accounts for most revenue, with Europe expanding through national reimbursement decisions and Japan and Australia following. Competition involves the category leader, European and emerging implant challengers, central sleep apnea specialists and daytime stimulation innovators.
The InsightAce study includes revenue forecasts in US$ for all device type, indication and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Sleep Apnea Neurostimulation Devices Market Snapshot
Chapter 4. Global Sleep Apnea Neurostimulation Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Device Type Estimates & Trend Analysis
5.1. Device Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Device Type:
5.2.1. Hypoglossal Nerve Stimulation Implants
5.2.2. Phrenic Nerve Stimulation for Central Sleep Apnea
5.2.3. Non-Implanted Daytime Neuromuscular Stimulation Devices
5.2.4. Emerging Bilateral and Leadless Stimulation Systems
Chapter 6. Market Segmentation 2: By Indication Estimates & Trend Analysis
6.1. Indication & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Indication:
6.2.1. Moderate to Severe Obstructive Sleep Apnea with CPAP Intolerance
6.2.2. Central Sleep Apnea
6.2.3. Mild Obstructive Sleep Apnea and Snoring
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. End User & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
7.2.1. Hospitals and Surgical Centers
7.2.2. Sleep Medicine and ENT Clinics
7.2.3. Home and Outpatient Use
Chapter 8. Sleep Apnea Neurostimulation Devices Market: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. United States
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. Japan
8.3.3. India
8.3.4. South Korea
8.3.5. Australia
8.3.6. Southeast Asia
8.3.7. Rest of Asia Pacific
8.4. Latin America
8.4.1. Brazil
8.4.2. Mexico
8.4.3. Rest of Latin America
8.5. Middle East & Africa
8.5.1. GCC Countries
8.5.2. South Africa
8.5.3. Rest of Middle East & Africa
Chapter 9. Competitive Landscape
9.1. Company Market Positioning Analysis
9.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 10. Company Profiles
10.1. Inspire Medical Systems, Inc.
10.2. Nyxoah SA
10.3. LivaNova PLC
10.4. ZOLL Medical Corporation (remede)
10.5. Signifier Medical Technologies Limited
10.6. Cryosa, Inc.
10.7. Invicta Medical, Inc.
10.8. Apnimed, Inc. (Adjacent Pharmacotherapy)
10.9. ResMed Inc.
10.10. Philips (Sleep and Respiratory Care)
10.11. ProSomnus, Inc.
10.12. SomnoMed Limited
10.13. Vivos Therapeutics, Inc.
10.14. Medtronic plc
10.15. Sleep Number Corporation (Adjacent)
圖表清單 List of Tables & Figures
Table 1. Global Sleep Apnea Neurostimulation Devices Market Revenue Forecast by Device Type, 2026-2035 (US$ Mn)
Figure 1. Global Sleep Apnea Neurostimulation Devices Market Segmentation Overview
Table 2. Global Sleep Apnea Neurostimulation Devices Market Revenue Forecast by Indication, 2026-2035 (US$ Mn)
Figure 2. Global Sleep Apnea Neurostimulation Devices Market Share by Device Type, 2026 & 2035
Table 3. Global Sleep Apnea Neurostimulation Devices Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 3. Sleep Apnea Treatment Pathway and Neurostimulation Eligibility After CPAP Failure
Table 4. North America Sleep Apnea Neurostimulation Devices Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 4. Global Sleep Apnea Neurostimulation Devices Market Share by Indication, 2026 & 2035
Table 5. Europe Sleep Apnea Neurostimulation Devices Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Implant Procedure Volumes and Trained Surgeon Capacity by Region, 2026-2035
Table 6. Asia Pacific Sleep Apnea Neurostimulation Devices Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Sleep Apnea Neurostimulation Devices Growth Opportunity Analysis
Table 7. Latin America Sleep Apnea Neurostimulation Devices Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Effect of Incretin Weight-Loss Therapies on Sleep Apnea Device Demand Scenarios
Table 8. Middle East & Africa Sleep Apnea Neurostimulation Devices Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Sleep Apnea Neurostimulation Devices Market Participants
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們